CD8A and neoplasm: Interestingly, when the clinical characteristics, including TMB, PDCD1 expression, CD8 T cell or M2 infiltration, mutational subtype, tumor stage, and prior ipilimumab treatment, were included as covariates in a multivariate Cox proportional hazards model, TIDE score no longer was no longer predictive of patient survival (Fig. 3B).